Fas and fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome

American Journal of Pathology

Volumn 161, Issue 5, 2002, Pages 1783-1796

  Albertine, Kurt H ^a   Soulier, Matthew F ^a   Wang, Zhengming ^a   Ishizaka, Akitoshi ^d   Hashimoto, Satoru ^e   Zimmerman, Guy A ^a   Matthay, Michael A ^b   Ware, Lorraine B ^c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d KEIO UNIVERSITY   (Japan)

^e KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; FAS LIGAND; PROTEIN BAX; PROTEIN P53;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; APOPTOSIS; ARTICLE; EDEMA; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LUNG ALVEOLUS WALL; LUNG EDEMA; LUNG INJURY; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; NICK END LABELING; PLASMA; PRIORITY JOURNAL;

EID: 0036841093     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64455-0     Document Type: Article

References (57)

1. Matthay MA, Wiener-Kronish JP: Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. Am Rev Respir Dis 1990, 142:1250-1257
2. Bachofen M, Weibel ER: Alterations of the gas exchange apparatus in adult respiratory insufficiency associated with septicemia. Am Rev Respir Dis 1977, 116:589-615
3. Hamann KJ, Dorscheid DR, Ko FD, Conforti AE, Sperling AI, Rabe KF, White SR: Expression of Fas (CD95) and FasL (CD95L) in human airway epithelium. Am J Respir Cell Mol Biol 1998, 19:537-542
4. Matute-Bello G, Liles WC, Steinberg KP, Kiener PA, Kiener S, Mongovin S, Chi EY, Jonas M, Martin TR: Soluble Fas-ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J Immunol 1999, 163:2217-2225
5. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis Cell 1991, 66:233-243
6. Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993, 75:1169-1178
7. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ, Mountz JD: Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994, 263:1759-1762
8. Tanaka M, Itai T, Adachi M, Nagata S: Downregulation of Fas ligand by shedding. Nat Med 1998, 4:31-36
9. Tanaka M, Suda T, Takahashi T, Nagata S: Expression of the functional soluble form of human fas ligand in activated lymphocytes. EMBO J 1995, 14:1129-1135
10. Arase H, Arase N, Saito T: Fas-mediated cytotoxicity by freshly isolated natural killer cells. J Exp Med 1995, 181:1235-1238
11. Nagafuji K, Shibuya T, Harada M, Mizuno SI, Takenaka K, Miyamoto T, Okamura T, Gondo H, Niho Y: Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood 1995, 86:883-889
12. Rouvier E, Luciani MF, Golstein P: Fas involvement in Ca(+2)-independent T cell-mediated cytotoxicity J Exp Med 1993, 177:195-200
13. Oyaizu N, Adachi Y, Hashimoto F, McCluskey TW, Hosaka N, Kayagaki N, Yagita H, Pahwa S: Monocytes express Fas ligand upon CD4 cross-linking and induce CD4+ T cell apoptosis: A possible mechanism of bystander cell death in HIV infection. J Immunol 1997, 158: 2456-2463
14. Savill J, Haslett C: Granulocyte clearance by apoptosis in the resolution of inflammation Semin Cell Biol 1995, 6:385-393
15. Liles WC, Kiener PA, Ledbetter JA, Aruffo A, Klebanoff SJ: Differential expression for Fas (CD95) and Fas ligand on normal human phagocytes: Implications for the regulation of apoptosis in neutrophils. J Exp Med 1996, 184:429-440
16. Ahmad R, Menezes J, Knafo L, Ahmad A: Activated human platelets express Fas-L and induce apoptosis of Fas-positive tumor dells. J Leukoc Biol 2001, 69:123-128
17. Lynch DH, Ramsdell F, Alderson MR: Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 1995, 16:569-574
18. Sato K, Kimura F, Nakamura Y, Murakami H, Yoshida M, Tanaka M, Nagata S, Kanatani Y, Wakimoto N, Nagata N, Motoyoshi K: An aggressive nasal lymphoma accompanied by high levels of soluble Fas ligand Br J Haematol 1996, 94:379-382
19. Tanaka M, Suda T, Haze K, Nakamura N, Sato K, Kimura F, Motoyoshi K, Mizuki M, Tagawa S, Ohga S, Hatake K, Drummond AH, Nagata S: Fas ligand in human serum. Nat Med 1996, 2:317-322
20. Yamaguchi S, Yamaoka M, Okuyama M, Nitoube J, Fukui A, Shirakabe M, Shirakawa K, Nakamura N, Tomoike H: Elevated circulating levels and cardiac secretion of soluble Fas ligand in patients with congestive heart failure. Am J Cardiol 1999, 83:1500-1503
21. Kuwano K, Miyazaki H, Hagimoto N, Kawasaki M, Fujita M, Kuitake R, Kaneko Y, Hara N: The involvement of Fas-Fas ligand pathway in fibrosing lung diseases Am J Respir Cell Mol Biol 1999, 20:53-60
22. Kuwano K, Hagimoto N, Kawasaki M, Nakamura N, Shirakawa K, Maeyama T, Hara N: Expression of FasL and Fas protein and their soluble form in patients with hypersensitivity pneumonitis. Int Arch Allergy Immunol 2000, 122:209-215
23. Kuwano K, Kawasaki M, Maeyama T, Hagimoto N, Nakamura N, Shirakawa K, Hara N: Soluble form of fas and fas ligand in BAL fluid from patients with pulmonary fibrosis and bronchiolitis obliterans organizing pneumonia. Chest 2000, 118:451-458
24. Hashimoto S, Kobayashi A, Kooguchi K, Kitamura Y, Onodera H, Nakajima H: Upregulation of two death pathways of perforin/granzyme and FasL/Fas in septic acute respiratory distress syndrome. Am J Respir Crit Care Med 2000, 161:237-243
25. Wen LP, Madani K, Fahrni JA, Duncan SR, Rosen GD: Dexamethasone inhibits lung epithelial cell apoptosis induced by IFN-gamma and Fas. Am J Physiol 1997, 273:L921-L929
26. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Le Gall JR, Morris A, Spragg R: The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination Am J Respir Crit Care Med 1994, 149:818-824
27. Fein A, Grossman RF, Jones JG, Overland E, Pitts L, Murray JF, Staub NC: The value of edema protein measurements in patients with pulmonary edema. Am J Med 1979, 67:32-38
28. Verghese GM, Ware LB, Matthay BA, Matthay MA: Alveolar epithelial fluid transport and the resolution of clinically severe hydrostatic pulmonary edema. J Appl Physiol 1999, 87:1301-1312
29. Ware LB, Matthay MA: Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome Am J Respir Crit Care Med 2001, 163:1376-1383
30. Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPSII) based on a European/North American multicenter study. JAMA 1993, 270:2957-2963
31. Murray JF, Matthay MA, Luce JM, Flick MR: An expanded definition of the adult respiratory distress syndrome Am Rev Respir Dis 1988, 138:720-723
32. Doyle RL, Szaflarski N, Modin GW, Wiener-Kronish JP, Matthay MA: Identification of patients with acute lung injury. Predictors of mortality. Am J Respir Crit Care Med 1995, 152:1818-1824
33. Imaizumi TA, Albertine KH, Jicha DL, McIntyre TM, Prescott SM, Zimmerman GA: Human endothelial cells differentially express and secrete ENA-78 and IL-8 when stimulated with inflammatory cytokines. Am J Respir Cell Mol Biol 1997, 17:181-192
34. Kohno N, Kyoizumi S, Awaya Y, Fukuhara H, Yamakido M, Akiyama M: New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6. Chest 1989, 96:68-73
35. Kohno N, Akiyama M, Kyoizumi S, Hakoda M, Kobuke K, Yamakido M: Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. Jpn J Clin Oncol 1988, 18:203-216
36. Zar JH: Biostatistical Analysis, ed 2. Englewood Cliffs, Prentice-Hall, Inc., 1984, pp 122-205
37. Nagata S: Apoptosis by death factor. Cell 1997, 88:355-365
38. Rathmell JC, Thompson CB: The central effectors of cell death in the immune system. Annu Rev Immunol 1999, 17:781-828
39. Kitamura Y. Hashimoto S, Mizuta N, Kobayashi A, Kooguchi K, Fujiwara I, Nakajima H: Fas/FasL-dependent apoptosis of alveolar cells after lipopolysaccharide induced lung injury in mice. Am J Respir Crit Care Med 2001, 163:762-769
40. Matute-Bello G, Winn RK, Jonas M, Chi EY, Martin TR, Liles WC: Fas (CD95) induces alveolar epithelial cell apoptosis in vivo. Implications for acute pulmonary inflammation. Am J Pathol 2001, 158:153-161
41. Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Matuschak GM, Buchman TG, Karl IE: Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 1999, 27:1230-1251
42. Hagimoto N, Kuwano K, Miyazaki H, Kunitake R, Fujita M, Kawasaki M, Kaneko Y, Hara N: Induction of apoptosis and pulmonary fibrosis in mice in response to ligation of fas antigen. Am J Respir Cell Mol Biol 1997, 17:272-278
43. Kuwano K, Hagimoto N, Kawasaki M, Yatomi T, Nakamura N, Nagata S, Suda T, Kunitake R, Maeyama T, Miyazaki H, Hara N: Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis. J Clin Invest 1999, 104:13-19
44. Bardales RH, Xie SS, Schaefer RF, Hsu SM: Apoptosis is a major pathway responsible for the resolution of type II pneumocytes in acute lung injury. Am J Pathol 1996, 149:845-852
45. Matute-Bello G, Liles WC, Radella FI, Steinberg KP. Ruzinski JT, Jonas M, Chi EY, Hudson LD, Martin TR: Neutrophil apoptosis in the acute respiratory distress syndrome. Am J Respir Crit Care Med 1997, 156:1969-1977
46. Stefanec T: Endothelial apoptosis: Could it have a role in the pathogenesis and treatment of disease? Chest 2000, 117:841-854
47. McGuire WW, Spragg RG, Cohen AB, Cochrane CG: Studies on the pathogenesis of the adult respiratory distress syndrome J Clin Invest 1982, 69:543-553
48. Sallenave JM, Donnely SC, Grant IS, Robertson C, Gauldie J, Haslett C: Secretory leukocyte proteinase inhibitor is preferentially increased in patients with acute respiratory distress syndrome Eur Respir J 1999, 13:1029-1036
49. Lee WL, Downey GP: Leukocyte elastase Physiological functions and role in acute lung injury. Am J Respir Crit Care Med 2001, 164:896-904
50. Martin TR: Cytokines and the acute respiratory distress syndrome (ARDS): A question of balance. Nat Med 1997, 3:272-273
51. Koh T, Aynsley-Green A, Tarbit M, Eyre JA: Neural dysfunction during hypoglycaemia Arch Dis Child 1988, 63:1353-1358
52. Druilhe A, Wallaert B, Tsicopoulos A, Lapae Silva JR, Tillie-Leblond I, Tonnel AB, Pretolani M: Apoptosis, proliferation, and expression of Bcl-2, Fas, and Fas ligand in bronchial biopsies from asthmatics. Am J Respir Cell Mol Biol 1998, 19:747-757
53. Fine A, Anderson NL, Rothstein TL, Williams MC, Goochuico BR: Fas expression in pulmonary alveolar type II cells Am J Physiol 1997, 273:L64-L71
54. Serrao KL, Fortenberry JD, Owens ML, Harris FL, Brown LA: Neutrophils induce apoptosis of lung epithelial cells via release of soluble Fas ligand. Am J Physiol 2001, 280:L298-L305
55. Auten RL, Whorton MH, Mason SN: Blocking neutrophil influx reduces DNA damage in hyperoxia-exposed newborn rat lung. Am J Respir Cell Mol Biol 2002, 26:391-397
56. Albertine KH, Plopper CG: Perspective: DNA oxidation or apoptosis: Will the real culprit of DNA damage in hyperoxic lung injury please stand up? Am J Respir Cell Mol Biol 2002, 26:381-383
57. Hockenbery D, Zuther M, Hickey W, Nahn M: BCL2 protein is topographically restricted in tissue characterized by apoptotic cell death. Proc Natl Acad Sci USA 1991, 88:6961-6965